These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15078089)

  • 1. Slow conformational dynamics in the hamster prion protein.
    Kuwata K; Kamatari YO; Akasaka K; James TL
    Biochemistry; 2004 Apr; 43(15):4439-46. PubMed ID: 15078089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of Syrian hamster prion protein rPrP(90-231).
    Liu H; Farr-Jones S; Ulyanov NB; Llinas M; Marqusee S; Groth D; Cohen FE; Prusiner SB; James TL
    Biochemistry; 1999 Apr; 38(17):5362-77. PubMed ID: 10220323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical studies of conformational plasticity in a recombinant prion protein.
    Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
    Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the 132-160 region in prion protein conformational transitions.
    Torrent J; Alvarez-Martinez MT; Liautard JP; Balny C; Lange R
    Protein Sci; 2005 Apr; 14(4):956-67. PubMed ID: 15772306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locally disordered conformer of the hamster prion protein: a crucial intermediate to PrPSc?
    Kuwata K; Li H; Yamada H; Legname G; Prusiner SB; Akasaka K; James TL
    Biochemistry; 2002 Oct; 41(41):12277-83. PubMed ID: 12369815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics.
    Viles JH; Donne D; Kroon G; Prusiner SB; Cohen FE; Dyson HJ; Wright PE
    Biochemistry; 2001 Mar; 40(9):2743-53. PubMed ID: 11258885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of enzyme motions by solution NMR relaxation dispersion.
    Loria JP; Berlow RB; Watt ED
    Acc Chem Res; 2008 Feb; 41(2):214-21. PubMed ID: 18281945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation.
    Nicholson EM; Mo H; Prusiner SB; Cohen FE; Marqusee S
    J Mol Biol; 2002 Feb; 316(3):807-15. PubMed ID: 11866533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into the interaction between prion protein and nucleic acid.
    Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
    Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal domain of insulin-like growth factor (IGF) binding protein 6: conformational exchange and its correlation with IGF-II binding.
    Yao S; Headey SJ; Keizer DW; Bach LA; Norton RS
    Biochemistry; 2004 Sep; 43(35):11187-95. PubMed ID: 15366928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational changes and development of proteinase K resistance in surface-immobilized PrP.
    Leclerc E; Vetter S
    Arch Virol; 2008; 153(4):683-91. PubMed ID: 18278426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process.
    Lee S; Eisenberg D
    Nat Struct Biol; 2003 Sep; 10(9):725-30. PubMed ID: 12897768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypeptide chain folding in the hydrophobic core of hamster scrapie prion: analysis by X-ray diffraction.
    Inouye H; Kirschner DA
    J Struct Biol; 1998; 122(1-2):247-55. PubMed ID: 9724626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for slow motion in proteins by multiple refocusing of heteronuclear nitrogen/proton multiple quantum coherences in NMR.
    Dittmer J; Bodenhausen G
    J Am Chem Soc; 2004 Feb; 126(5):1314-5. PubMed ID: 14759169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for His155 in binding of human prion peptide144-167 to immobilised prion protein.
    Hesp JR; Raven ND; Sutton JM
    Biochem Biophys Res Commun; 2007 Oct; 362(3):695-9. PubMed ID: 17761148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative prion structural changes revealed by high pressure.
    Torrent J; Alvarez-Martinez MT; Heitz F; Liautard JP; Balny C; Lange R
    Biochemistry; 2003 Feb; 42(5):1318-25. PubMed ID: 12564935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
    Bertho G; Bouvier G; Hoa GH; Girault JP
    Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.